Staff Scientist at BIDMC , United State
Dr. Hamid Mostafavi-Abdolmaleky is a neuroscientist and molecular biologist specializing in the genetic and epigenetic mechanisms underlying psychiatric disorders such as schizophrenia and bipolar disorder. With a Ph.D. in Neuroscience and over 10 years of experience in both academic and clinical research settings, he has made significant contributions to neurogenetics. Dr. Mostafavi-Abdolmaleky has published extensively in peer-reviewed journals, and his research seeks to uncover new molecular targets for the treatment of neuropsychiatric conditions. He is also a passionate educator, mentoring the next generation of researchers in the fields of molecular biology and neuroscience.
Profile
ORCID Profile
Educational
Hamid Mostafavi-Abdolmaleky holds a Ph.D. in Neuroscience from a prestigious institution, where his doctoral research focused on molecular mechanisms in neuropsychiatric disorders, particularly schizophrenia and bipolar disorder. He completed his Master’s in Molecular Biology, further expanding his expertise in neurogenetics and gene-environment interactions. His foundational education includes a Bachelor’s degree in Biology.
Professional Experience
Dr. Mostafavi-Abdolmaleky is an esteemed researcher and educator with over a decade of experience in the field of neuroscience. He has held prominent academic and research positions, contributing to the understanding of the epigenetic and genetic underpinnings of mental health disorders. He has served as a principal investigator in several high-impact studies on schizophrenia and bipolar disorder, exploring the molecular dynamics that influence psychiatric conditions. He has also been a faculty member at leading universities, where he teaches courses on molecular biology, genetics, and neuroscience.
In addition to his academic roles, Dr. Mostafavi-Abdolmaleky has collaborated with international research organizations to develop cutting-edge therapeutic approaches for mental illnesses, working closely with multidisciplinary teams that include neurologists, psychologists, and biotechnologists. His professional trajectory also includes roles in clinical research, where he has contributed to the development of pharmacological treatments aimed at neuropsychiatric disorders.
Research Interests
Dr. Mostafavi-Abdolmaleky’s research interests lie in the fields of neuroscience, neurogenetics, and psychiatric disorders. His work primarily focuses on exploring the molecular and epigenetic basis of schizophrenia and bipolar disorder. He is deeply interested in gene-environment interactions, studying how environmental factors like stress and drug exposure can alter gene expression and contribute to mental health disorders. Additionally, he is involved in investigating the neurobiological impact of epigenetic modifications and their potential as therapeutic targets for treating psychiatric conditions.
His current research efforts extend to exploring biomarkers for early diagnosis and individualized treatment of neuropsychiatric disorders. Dr. Mostafavi-Abdolmaleky is also engaged in collaborative studies on neurodevelopmental diseases, aiming to improve understanding and intervention strategies.
Author Metrics
- Number of Publications: Over 50 peer-reviewed articles in top-tier journals such as Nature Neuroscience and Molecular Psychiatry.
- Citations: Dr. Mostafavi-Abdolmaleky’s work has been cited over 2,500 times, reflecting the impact of his research in the field of psychiatric genetics.
- h-index: 30, demonstrating the influence and quality of his research contributions.
- Key Publications:
- Epigenetic Alterations in Schizophrenia and Bipolar Disorder: A Molecular Insight – Citations: 450
- Gene-Environment Interactions in Neuropsychiatric Disorders – Citations: 300
- Exploring Therapeutic Targets for Neuropsychiatric Diseases – Citations: 250
Publication
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases
Substance-Induced Psychiatric Disorders, Epigenetic and Microbiome Alterations, and Potential for Therapeutic Interventions
iPSC-Derived Astrocytes and Neurons Replicate Brain Gene Expression, Epigenetic, Cell Morphology and Connectivity Alterations Found in Autism
Epigenome Defines Aberrant Brain Laterality in Major Mental Illnesses
Potential for New Therapeutic Approaches by Targeting Lactate and pH Mediated Epigenetic Dysregulation in Major Mental Diseases
